SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Follow-up) — Hippocrates

PatientHippocrates
Date of birth1937-01-10
IdentifiersMRN HR-AC005-SYN; SSN (made up) 000-05-8153
Document date2026-06-29
AuthorEleni Vasquez-Okafor, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-month review. [S]

History of Present Illness

Hippocrates finished twelve weeks of physical therapy and goes to tai chi twice a week. He walks into town for his teaching and stops once on the hill. His knees ache at 2 of 10 on the hill; he uses the gel most mornings and acetaminophen two or three times a week. He has had no falls and no dizziness. He takes vitamin D3 daily. He had the RSV and first zoster vaccines three weeks ago with a sore arm for a day. [S]

ElementDetail
MobilityGait speed 0.92 m/s; Timed Up and Go 11.4 seconds; 10 chair stands; tandem stance 10 seconds
Grip26 kg right, 24 kg left
KneePain 2 of 10; KOOS JR 74
Vitamin D33 ng/mL
FallsNone

Review of Systems

SystemResultFinding
MusculoskeletalPositiveKnee ache on the hill, 2 of 10
NeurologicalNegativeNo dizziness
ConstitutionalNegativeEnergy good; weight steady

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen sodium 220 mg oral tablet, one or two tablets most days for knee pain, bought over the counter, for about two years; stopped at intake (Beers 2023: avoid chronic use)One or two tablets by mouth up to twice a day, self-directedOral route2024-03-01 to 2026-03-02stoppedS
Diphenhydramine 25 mg oral capsule at bedtime three or four nights a week for sleep, bought over the counter; stopped at intake (Beers 2023: strongly anticholinergic)One capsule at bedtime as needed, self-directedOral route2025-09-01 to 2026-03-02stoppedS
Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee pain, no more than 3,000 mg in a dayOne to two tablets by mouth every eight hours as needed; no more than six tablets a dayOral route2026-03-02activeS
Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once dailyOne tablet by mouth dailyOral route2026-03-02activeS
Diclofenac 1% gel, 4 g rubbed into each painful knee up to four times a dayApply 4 g to each painful knee up to four times a dayTopical route2026-03-16activeS
Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestionTwo sprays in each nostril up to every four hours as neededNasal route2026-04-13 to 2026-04-23completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-29Body height168cmS
2026-06-29Body weight64.6kgS
2026-06-29Body mass index (BMI) [Ratio]22.9kg/m2S
2026-06-29Systolic blood pressure132mm[Hg]S
2026-06-29Diastolic blood pressure72mm[Hg]S
2026-06-29Heart rate64/minS
2026-06-29Respiratory rate16/minS
2026-06-29Body temperature36.5CelS
2026-06-29Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-2925-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma33ng/mLBelow 20 ng/mL deficient; 20 to 29 insufficientNormalS
2026-06-29Grip strength Hand - left Dynamometer24kgS
2026-06-29Grip strength Hand - right Dynamometer26kgS
2026-06-29Total interval score [KOOSJR]74{score}S
2026-06-29Pain severity - 0-10 verbal numeric rating [Score] - Reported2{score}S

Physical Exam

Vital signs recorded on 2026-06-29; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 132/72 seated and 130/72 standing; pulse 64; weight 64.6 kg
MusculoskeletalBoth knees: crepitus, no effusion; quadriceps 5 of 5 on the right, 4+ of 5 on the left
NeurologicalRises from a chair without his arms; turns steadily

Problems

ProblemClinical statusVerificationCodeProvenance
Slower walking, knee pain on stairs and one near-fall in the past six months, found on the comprehensive geriatric assessment at intake: gait speed 0.78 m/s, Timed Up and Go 13.8 seconds, unable to hold a tandem stance for 10 seconds, grip 24 kg; cause under evaluation with a geriatric medicine consultationresolvedconfirmed R26.81S — Synthetic presenting problem of normal aging found on a comprehensive geriatric assessment; superseded at the consultation, when knee osteoarthritis with reduced leg strength and balance was diagnosed.
Primary osteoarthritis of both knees, diagnosed clinically by the ACR criteria (knee pain, age over 50, morning stiffness under 30 minutes, crepitus, bony enlargement, no warmth), with reduced quadriceps strength and balance and an increased risk of falls; KOOS JR 62activeconfirmed M17.0S — Synthetic modern diagnosis made at the consultation: a common, mild condition of aging chosen for a figure with no documented illness; not a claim about his real knees.
Potentially inappropriate over-the-counter medicines (Beers 2023): naproxen most days for about two years and diphenhydramine for sleep three or four nights a week; both stopped at intakeresolvedconfirmed Z79.1S — Synthetic medication history found on the deprescribing review.
Low bone mass (femoral neck T-score -1.7, total hip -1.4) with vitamin D insufficiency (24 ng/mL); FRAX 10-year risk 11 percent major and 2.6 percent hip, below treatment thresholdsactiveconfirmed M85.89S — Synthetic DXA finding at eight weeks; not a claim about his real bones.
Common cold (viral upper respiratory infection) with runny nose, sore throat and a mild cough, no fever, chest clear, oxygen saturation 97 percent; COVID-19 and influenza tests negative; resolved in about ten daysresolvedconfirmed J06.9S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyKnee pain (0 to 10)Every visitCompleted today2 of 10
SurveyKnee function (KOOS JR)Every visitCompleted today74, from 62 at intake
ExaminationKnee examination (range of movement, effusion, alignment, crepitus)Every visitCompleted todayCrepitus, no effusion; quadriceps 5 and 4+ of 5
Self-managementExercise and self-management (strength and balance program, tai chi)Every visitCompleted todayTwelve weeks of physical therapy finished; tai chi twice a week
ExaminationGait speed, Timed Up and Go, 30-second chair stand and four-stage balance testAt intake and after a strength and balance programCompleted todayGait speed 0.92 m/s (from 0.78); Timed Up and Go 11.4 seconds (from 13.8); 10 chair stands (from 7); tandem stance 10 seconds (from 6)
ExaminationGrip strengthAt intake and after the programCompleted today26 kg right, 24 kg left (from 24 and 22)
ExaminationOrthostatic blood pressureAt assessment and with any dizzinessCompleted today132/72 seated, 130/72 standing
Medication safetyMedication review (Beers 2023): no NSAID tablets, sedating antihistamines or other anticholinergic medicines; over-the-counter purchasesEvery visitCompleted todayNo NSAID tablets, sleep aids or cold remedies
Medication safetyTopical diclofenac: skin and useEvery visitCompleted todayMost mornings; no skin irritation
Laboratory25-hydroxyvitamin DAt baseline, after repletion, then yearlyCompleted today33 ng/mL after four months of vitamin D3, from 24
ImagingDXA and FRAXAt assessment, then every two years if untreatedUp to dateDone at eight weeks; repeat in two years
SurveyWhat matters most (4Ms)Every visitCompleted todayWalking to his teaching, one stop on the hill
SurveyMentation: mood, memory and sleep (4Ms)Every visitCompleted todayMini-Cog 5 and PHQ-2 0 at the wellness visit; sleeping well

Goal progress:

Guideline basis: Age-Friendly Health Systems: the 4Ms (What Matters, Medication, Mentation, Mobility) (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Updating STEADI for Primary Care: Recommendations From the American Geriatrics Society Workgroup (2025); World guidelines for falls prevention and management for older adults: a global initiative (2022); Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management (2019); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); The clinician's guide to prevention and treatment of osteoporosis (2022); CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis, and osteoporosis monographs (2026)

Follow-up: Seven-month review in three months with the second zoster dose and the influenza vaccine. The clinic for any fall. Next scheduled visit 2026-09-28: seven-month review: knee function, mobility, falls, medicines, vaccines and what matters most to him. [S]